Plaintiff

Supio Secures $25 Million to Revolutionize Plaintiff Law Firms with Cutting-Edge AI Technology

by

San Francisco, CA – Emerging from stealth mode, Supio has recently announced a substantial $25 million Series A funding to revolutionize the legal tech field. The company, which specializes in artificial intelligence, aims to equip personal injury and mass tort plaintiff law firms with advanced tools to enhance their operational efficacy. This financial infusion is led by a mix of veteran venture capitalists and tech entrepreneurs, reflecting a strong vote of confidence in Supio’s pioneering technology aimed at legal professionals. The investment will empower the company to expand its AI capabilities, which promise to streamline … Read more

$63.4 Million Verdict Against Johnson & Johnson in Mesothelioma Talc Case: South Carolina Jury Finds for Plaintiff

by

Columbia, SC – In a landmark decision, a jury in South Carolina awarded $63.4 million to a man who claims he developed cancer due to prolonged exposure to asbestos in Johnson & Johnson’s talcum powder products. The verdict was issued on Thursday following a closely watched trial that scrutinized the potential health risks of one of the company’s iconic products. The plaintiff, Michael Perry, 53, was awarded $32.6 million in compensatory damages after jurors concluded that his mesothelioma, a type of cancer often associated with asbestos exposure, was indeed caused by his lifelong use of … Read more

Merck Resolves Over 1,000 Zostavax Lawsuits Following Plaintiff Dismissals

by

Rahway, New Jersey — Merck & Co., a leading pharmaceutical company, has reached a significant legal milestone by resolving over a thousand lawsuits connected to its shingles vaccine, Zostavax. The cases were concluded following the plaintiffs’ decision to request dismissals, thus eliminating a batch of longstanding legal grievances against the drugmaker. Zostavax, designed to prevent shingles in older adults, was approved by the U.S. Food and Drug Administration in 2006. Marketed until its production ceased in 2020, it was the only shingles vaccine available in the U.S. for a decade before competitors like Shingrix emerged. … Read more

From Behind Bars to Lead Plaintiff: Virginia Man Sues Over Extended Sentence Despite New Early Release Law

by

Richmond, VA – After a grueling 11 years behind bars for attempted robbery and firearms use, Leslie Puryear anticipated his freedom, bolstered by a Virginia law designed to reduce prison sentences for exemplary conduct and rehabilitation efforts. As part of a 2020 criminal justice reform borne out of nationwide calls for a more equitable system, Puryear had qualified for early release, only to find his dreams dashed when corrections officials recalculated his sentence, adding three more years to his time in prison. Initially encouraged by the reforms, which promised a significant decrease of his 18-year … Read more